Cargando…
Chordoma: The Quest for Better Treatment Options
Chordoma is an extremely rare cancer, with an incidence of about one case per million persons per year in the USA and Europe (about 300 and 450 cases per year, respectively). The estimated median overall survival of patients with chordoma is approximately 6–7 years, yielding a rough estimate of chor...
Autor principal: | Heery, Christopher R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5315072/ https://www.ncbi.nlm.nih.gov/pubmed/28261639 http://dx.doi.org/10.1007/s40487-016-0016-0 |
Ejemplares similares
-
Erratum to: Chordoma: The Quest for Better Treatment Options
por: Heery, Christopher R.
Publicado: (2016) -
Radiotherapy in bone sarcoma: the quest for better treatment option
por: Locquet, Marie-Anaïs, et al.
Publicado: (2023) -
Therapeutic Cancer Vaccines in Prostate Cancer: The Quest for Intermediate Markers of Response
por: Kim, Joseph W., et al.
Publicado: (2012) -
Immunotherapy as a Promising Option for the Treatment of Advanced Chordoma: A Systemic Review
por: Wang, Xiang, et al.
Publicado: (2022) -
Hyperthermia and Serotonin: The Quest for a “Better Cyproheptadine”
por: Petroianu, Georg A.
Publicado: (2022)